레이: insider trades · South Korea · DART (FSS) DART:company-3657fe KR KR · DART (FSS) Mcap 116.5Bn€ Healthcare
Discover the full management transaction log of 레이, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 레이 has recorded 10 public disclosures. Market capitalisation: €116.5bn. The latest transaction was filed on 15 May 2026 (Other). Among the most active insiders: 메가젠임플란트. Every trade is accessible without an account.
€117,409
2 ops.
Sell Volume
Financial data FY ended December 2025 · cache
Analyst consensus
1 analysts · 12500.00 € Target 12500.00 €(+67%) 12500.00 €
Income statement
Revenue 111.32 Bn€
Gross profit 52.75 Bn€ 47% margin
Net income 3.14 Bn€ 2.8% margin
Valuation
PER (forward) 10.2x
Beta 1.29
Balance sheet & cash
Market cap 116.55 Bn€
Total debt 80.66 Bn€
Free Cash Flow 9.23 Bn€
Debt / Equity 108%
Profitability & ownership
ROE 0.6%
ROA -3.1%
% insiders 33.7%
% institutions 2.6%
Last declaration on 15 May 2026
Declarations 10 total
Executives ● Other0 DART
DART:20260515002905 · 15 May 2026 details not loaded
Executives ● Other0 DART
DART:20260514001488 · 14 May 2026 details not loaded
Executives ● Purchase21 DART
€5,354 1,500 shares @ €3.5692 0.0000% mcap 100.0% of flow
DART:20260514000633 · 4 Mar 2026
Ideal exit: 29 Nov 2026 (T+270) Executives ● Other0 DART
DART:20260513000876 · 13 May 2026 details not loaded
Executives ● Purchase4 DART
€188,538 44,149 shares
DART:20260507000665 · 7 May 2026
Ideal exit: 1 Feb 2027 (T+270) Executives ● Sale4 DART
€117,409 27,493 shares
DART:20260507000100 · 7 May 2026
Executives ● Purchase4 DART
€2m 800,360 shares
DART:20260408003346 · 8 Apr 2026
Ideal exit: 3 Jan 2027 (T+270) Executives ● Other4 DART
0
DART:20260401001660 · 1 Apr 2026
Executives ● Other4 DART
0
DART:20260325000502 · 25 Mar 2026
Executives ● Sale0 DART
27,493 shares
DART:20210224000416 · 24 Feb 2021